期刊文献+

N-亚甲基磷酸化壳聚糖基因纳米粒子的体外细胞毒性及基因转染实验研究 被引量:1

Study on the cytotoxicity and gene transfection of NMPCS/DNA nanoparticles
原文传递
导出
摘要 目的 考察N-亚甲基磷酸化壳聚糖( NMPCS)基因纳米粒子的体外细胞毒性及基因转染效率.方法 采用均相反应法制备了NMPCS,用复凝聚法制备了NMPCS/DNA纳米粒子;通过MTT实验考察了NMPCS及其与DNA复合物对HeLa细胞的细胞毒性,以荧光索酶质粒为报告基因考察了NMPCS及NMPCS-CaZ+载体介导的体外基因转染效率.结果 NMPCS及其与DNA的复合物在体外表现出很小的细胞毒性,远远低于同等浓度时聚乙烯亚胺(PEI)的毒性.通过对壳聚糖进行亚甲基磷酸化修饰后,可大幅提高载体的基因转染效率.结论 N-亚甲基磷酸化壳聚糖有望成为一种新型、安全、高效的非病毒基因载体. Objective To investigate the cytotoxicity and gene transfection mediated by NMPCS/DNA nanoparticles. Methods N-methylene phosphonic chitosan (NMPCS) was synthesized using one-step reaction under homogeneous conditions. The NMPCS/DNA nanoparticles were prepared using complex coacervation method. The cytotoxicity of NMPCS alone and its complexes with plasmid DNA were determined by MTF assay on HeLa cells. The gene transfection mediated by NMPCS/DNA nanoparticles were investigated using pGL3-control vector as reporter gene. Results The MTF results suggested that the NMPCS and NMPCS/DNA complexes showed significantly lower cytotoxicity than PEI and PEI/DNA complexes, respectively. The gene transfection mediated by NMPCS/DNA nanoparticles were greatly improved compared with unmodified chitosan. Conclusion NMPCS would demonstrate great potential as a novel, safe, efficient non-viral vector for gene delivery.
出处 《国际生物医学工程杂志》 CAS 2012年第3期165-168,F0003,共5页 International Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(81100100) 天津市自然科学基金面上项目(10JCYBJC10600) 教育部新教师基金(20091106120048) 协和青年科研基金资助项目
关键词 亚甲基磷酸化壳聚糖 非病毒载体 基因转染 Methylene phosphonic chitosan Non-viral vector Gene transfection
  • 相关文献

参考文献16

  • 1Bordignon C, Notarangelo LD, Nobili N, et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodefieient patients[J]. Science, 1995,270(5235): 470-475.
  • 2Jafari M, Soltani M, Naahidi S, et al. Nonviral approach for targeted nucleic acid delivery[J]. Curr Med Chcm, 2012, 19(2): 197-208.
  • 3吴海霞,张维铭,李晓眠.基因转染技术的发展与现状[J].国际生物医学工程杂志,2007,30(6):376-379. 被引量:7
  • 4Ishikawa K, Tilemann L, Fish K, et al. Gene delivery methods in cardiac gene therapy[J]. J Gene Med, 2011, 13(10): 566-572.
  • 5Heilbronn R, Weger S. Viral vectors for gene transfer: current status of gene therapeutics[J]. Handb Exp Pharmacol, 2010, 197(2):143-170.
  • 6Marshall E. Gene therapy on trial[J]. Science, 2000, 288(5468): 951- 957.
  • 7Khan TA, Sellke FW, Laham RJ. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia[J]. Gene Ther, 2003, 10(4): 285-291.
  • 8Knowles MR, Hohneker KW, Zhou Zhao-qing, et at. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis[J]. N Engl J Med, 1995, 333 (13): 823-831.
  • 9Liu Chun-xi, Zhang Na. Nanoparticles in gene therapy principles, prospects, and challenges[J]. ProgMol Biol Transl Sei, 2011, 104: 509-562.
  • 10Pathak A, Patnaik S, Gupta KC. Recent trends in non-viral vector- mediated gene delivery[J]. Biotechnol J, 2009, 4(11): 1559-1572.

二级参考文献46

共引文献9

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部